Introduction
Pulmonary Langerhans Cell Histiocytosis (PLCH) is a rare form of interstitial lung diseases that primarily affects young adults (1) (2) (3) (4) (5) . The certain incidence and prevalence are unknown. No occupational or geographic predisposition has been reported, but majority of the affected population have a history of ongoing or past smoking. The Langerhans cell is the pathologic cell type of PLCH. Langerhans cells also demonstrate positive immunohistochemical staining for S100 protein and have strong presence of CD1 antigen (CD1a) on the cell surface. Patients with PLCH are mostly determined by sole or combination of several altered presentations such as; incidentally detected findings on chest radiographs including a spontaneous pneumothorax and/or with respiratory or constitutional symptoms (6, 7) . High resolution computed tomography (HRCT) of the chest can provide significant data to lead the diagnosis. A combination of the features such as stellate nodules lung volume and costophrenic angle sparing are highly specific for PLCH (8, 9) . Because of the rarity; we reported the varied radiological features of two cases with a histologically and radiologically confirmed diagnosed of PLCH.
Case report
Case 1: A 30 years old man referred with a two month history of dyspnea, cough, sputum and night sweats. Before his admission, he had an antibiotherapy in another epicenter, his complaints have regressed. He was referred to our hospital because of the persevering abnormalities detected on chest radiographs. On his initial admission; physical examination and routine hematology parameters including ESR were within normal ranges (ESR was 7 mm at the end of first hour). Sputum cultures including for tuberculosis were negative. Blood gases and pulmonary function tests were normal. In anamnesis, he had a 10 pack/year smoking history. The chest X-ray revealed reticulonodular opacities at the perifery of the upper and middle zones. In thorax computed tomography (CT) examination; pulmonary parenchymal nodules with a range of 1-5 mm in diameter were detected, lesions were mostly with centrilobular distribution (arrows), but a few were located at subpleural region (arrow head). Magnified investigation of the pulmonary parenchyma on chest CT revealed central hypo-dense components leading cavitation (Image 1a,b). Open lung biopsy performed to the patient, immunohistochemical examination CD1a, CD68, S100 detecting antigen-positive and langerhans cell histiocytosis diagnosed (Figure 1 a,b,c). Fluorodeoxyglucose-PET (FDG-PET) was performed the patient for determining the systemic involvement, FDG PET imaging was negative. Smoking cessation was recommended, he stopped smoking and still in follow up.
Image 1.
Chest CT image from a 27-year-old smoker male with biopsy-proven Pulmonary Langerhans cell histiocytosis demonstrating multiple pulmonary nodules which mostly pronounced early in the disease. a) Nodules were 1-5 mm in diameter, mostly with centrilobular distribution (arrows), but a few were located at subpleural region (arrow head). b) Magnified examination on chest CT revealed central hypo-dense components leading cavitation. 
Discussion
The histiocytic disorders are rare conditions characterized by abnormal infiltration of specific organs by cells reproduced from monocyte/macrophage or dendritic cell origin. Langerhans cell histiocytosis (LCH) is a specific type of histocytic syndromes which is characterized by infiltration of the tissues with Langerhans cells (10) . LCH may affect an isolated organ or may act as a multisystemic disease (formerly termed as HandShuller-Christian or Letterer-Siwe disease) (11) . In our cases, pulmonary involvement patterns were demonstrated solely. The signs and symptoms of PLCH are nonspecific and should prompt consideration of superimposed infection such as Aspergillus or tumor (12, 13) . Nonproductive cough, dyspnea and pleuritic chest pain are the most common symptoms (1, 5, 14) . Cough was the most frequent symptom in our cases. The pulmonary involvement by the disease predominates in the mid to upper zones of the lung and spares the costophrenic angle which is in contrast with the typical lower zone involvement of idiopathic pulmonary fibrosis (8, 15) . Lesions frequently extend widely into the parenchyma of the lung surrounding the bronchovascular structures, producing the socalled stellate lesions that are characteristic of this disorder. Interstitial fibrosis and small cyst formation occur with advancing disease; the mechanism for cyst formation is unknown (7) . Reticulonodular infiltrations are dominant findings in chest CT in early stage whereas cystic lesions and emphysema are more predominant in advanced stage. In the first case of our report; reticulonodular infiltrates were predominant, cavitated nodules located at the peribronchial and centrilobular region were determined. These findings supported that the disease was at its' early stage. However; in the second case, findings including diffuse cyst formations located at the upper and middle zones of the pulmonary parenchyma indicated that the disease was on an advanced stage especially when compared with the first case. The clinical signs and symptoms of PLCH are mostly may not be sufficient to distinguish itself from other non-specific pulmonary diseases. HRCT of the chest can provide an accurate final diagnosis if is demonstrating well-described CT findings of the issue, as particularly in the second case. (20, 21) . Langerhans cells also demonstrate positive immunohistochemical staining for S100 protein and have strong presence of CD1 antigen (CD1a) on the cell surface. In the first case open lung biopsy specimens showed CD1a, CD68, S100 detecting antigen-positive and langerhans cell histiocytosis diagnosed. There is no widely accepted definite treatment guideline protocol for PLCH management in recent literature except a few recommendations that were reported regarding to treatment of adult patients with PLCH The most effective component of the PLCH treatment is indicated as smoking cessation. It was reported that the smoking cessation may solely prevent the progression of the disease so, it should be strongly encouraged (14, 21) .
In conclusion, PLCH is an extremely rare benign disease. The patients could referred with different clinically and radiologically findings.
